A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : IGIV / immune globulin intravenous

[Related PubMed/MEDLINE]
Total Number of Papers: 21
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   IGIV  (>> Co-occurring Abbreviation)
Long Form:   immune globulin intravenous
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2016 Transient Deformation of Neutrophils in Kawasaki Disease. ---
2014 Safety and tolerability of immune globulin intravenous (human), 10% solution in Japanese subjects with mild to moderate Alzheimer's disease. TEAE
2008 A newer immunoglobulin intravenous (IGIV) - Gammagard liquid 10%: evaluation of efficacy, safety, tolerability and impact on patient care. ---
2006 Adverse events associated with intravenous immunoglobulin therapy. FDA
2006 Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases. AMBD, BP, CIST, MMP, OCP, PV
2006 Differences between IGIV products: impact on clinical outcome. ---
2006 Fc function of a new intravenous immunoglobulin product: IGIV 10% triple virally inactivated solution. EP
2006 IGIV: contents, properties, and methods of industrial production--evolving closer to a more physiologic product. ---
2006 Use of intravenous immunoglobulin therapy in autoimmune blistering diseases. AMBD
10  2005 Clinical and investigational considerations for the use of IGIV therapy. Fc
11  2005 Pharmacy considerations for the use of IGIV therapy. FDA
12  1999 Availability of immune globulin intravenous for treatment of immune deficient patients--United States, 1997-1998. FDA, IDF
13  1999 IGIV in neurology--evidence and recommendations. ---
14  1999 Renal insufficiency and failure associated with immune globulin intravenous therapy--United States, 1985-1998. FDA, HIV-1, IgG, RAEs
15  1990 Increased proliferation of blood mononuclear cells after plasmapheresis treatment of patients with demyelinating disease. GBS, MS
16  1989 Effect of immune globulin intravenous on opsonization of bacteria by classic and alternative complement pathways in premature serum. ---
17  1989 Mechanisms of bacterial opsonization by immune globulin intravenous: correlation of complement consumption with opsonic activity and protective efficacy. PMNL
18  1989 Prophylaxis and treatment of pneumococcal bacteremia by immune globulin intravenous in a mouse model. ---
19  1984 Comparison of varicella zoster antibody titers in patients given intravenous immune serum globulin or varicella zoster immune globulin. ELISA, IFA, RIA
20  1983 Immune globulin intravenous replacement after plasma exchange. ISG
21  1983 The interaction of immune serum globulin and immune globulin intravenous with complement. ISG